Efficacy and safety of secukinumab in the treatment of chronic plaque psoriasis: A 52-weeks follow up study. Journal of Pakistan Association of Dermatologists, [S. l.], v. 34, n. 1, p. 191–199, 2024. DOI: 10.66344/jpad.v34i1.2545. Disponível em: https://www.jpad.com.pk/index.php/jpad/article/view/2545. Acesso em: 27 jul. 2026.